- Home
- FLR vs PCVX Comparison
FLR vs PCVX Comparison
Compare FLR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLR
- PCVX
- Stock Information
- Founded
- FLR 1912
- PCVX 2013
- Country
- FLR United States
- PCVX United States
- Employees
- FLR N/A
- PCVX N/A
- Industry
- FLR Military/Government/Technical
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- FLR Industrials
- PCVX Health Care
- Exchange
- FLR Nasdaq
- PCVX Nasdaq
- Market Cap
- FLR 8.4B
- PCVX 14.7B
- IPO Year
- FLR N/A
- PCVX 2020
- Fundamental
- Price
- FLR $53.86
- PCVX $115.61
- Analyst Decision
- FLR Buy
- PCVX Strong Buy
- Analyst Count
- FLR 7
- PCVX 7
- Target Price
- FLR $54.71
- PCVX $147.50
- AVG Volume (30 Days)
- FLR 1.8M
- PCVX 709.4K
- Earning Date
- FLR 11-08-2024
- PCVX 11-04-2024
- Dividend Yield
- FLR N/A
- PCVX N/A
- EPS Growth
- FLR N/A
- PCVX N/A
- EPS
- FLR 2.24
- PCVX N/A
- Revenue
- FLR $15,743,000,000.00
- PCVX N/A
- Revenue This Year
- FLR $13.78
- PCVX N/A
- Revenue Next Year
- FLR $8.89
- PCVX N/A
- P/E Ratio
- FLR $24.03
- PCVX N/A
- Revenue Growth
- FLR 4.86
- PCVX N/A
- 52 Week Low
- FLR $32.31
- PCVX $45.00
- 52 Week High
- FLR $55.75
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- FLR 68.61
- PCVX 59.44
- Support Level
- FLR $50.32
- PCVX $109.68
- Resistance Level
- FLR $55.75
- PCVX $118.62
- Average True Range (ATR)
- FLR 1.49
- PCVX 2.99
- MACD
- FLR 0.53
- PCVX -0.49
- Stochastic Oscillator
- FLR 79.55
- PCVX 74.07
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $15.5 billion in revenue in 2023.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.